We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.22B
AUM Growth
-$873M
Cap. Flow
-$1.18B
Cap. Flow %
-28.02%
Top 10 Hldgs %
31.05%
Holding
110
New
22
Increased
26
Reduced
27
Closed
30

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$94.6M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$79.4M
3
ZBH icon
Zimmer Biomet
ZBH
+$78.6M
4
DVA icon
DaVita
DVA
+$74.5M
5
HOLX
Hologic
HOLX
+$69M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$103M
2
CNC icon
Centene
CNC
+$85.6M
3
AGN.PRA
Allergan plc
AGN.PRA
+$79.2M
4
JD icon
JD.com
JD
+$78.6M
5
ELV icon
Elevance Health
ELV
+$77.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.28%
2 Technology 12.7%
3 Communication Services 3.9%
4 Financials 3.09%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENT
101
DELISTED
Intersect ENT, Inc
XENT
-768,366
Closed -$23.9M
PRAH
102
DELISTED
PRA Health Sciences, Inc.
PRAH
-113,283
Closed -$8.63M
AGN
103
DELISTED
Allergan plc
AGN
-428
Closed -$88K
AGN.PRA
104
DELISTED
Allergan plc
AGN.PRA
-107,410
Closed -$79.2M
KITE
105
DELISTED
Kite Pharma, Inc.
KITE
-2,944
Closed -$529K

Similar funds

PFM Health Sciences's Q4 2017 Portfolio in Review

As of Q4 2017, PFM Health Sciences held 110 positions worth $4.22B, down 17% from $5.09B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $1.18B in Q4 2017, closing 30 positions and reducing 27 holdings. Its most notable exit was Centene, an estimated $85.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Baidu worth $90.7M.

  • PFM Health Sciences's largest Q4 2017 buy was Baidu: 387,046 shares worth $90.7M.
  • PFM Health Sciences added most to Puma Biotechnology in Q4 2017, an estimated $50.6M increase.
  • PFM Health Sciences's biggest Q4 2017 reduction was Meta Platforms (Facebook), cutting an estimated $103M.
  • PFM Health Sciences fully exited Centene in Q4 2017, selling an estimated $85.6M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $4.22B portfolio in Q4 2017.
  • PFM Health Sciences opened 22 new positions and closed 30 in Q4 2017.
  • PFM Health Sciences's portfolio value fell 17% quarter-over-quarter to $4.22B.

Based on PFM Health Sciences's 13F filing for Q4 2017, filed 14 Feb 2018.